10:01:32 [Rx]&mtrsl|idBMX|pi10758314|pnInterface|psa|plPUM|p2PUM|pa09/05/2011|pda|p6Adult|si|s&013|ssBlood|s5Blood|s109/05/2011|s214:57|s309/01/2011|s408:12|ci20110831L4B0002|&c01|ctbcilnk|cnBCI Download Exam|c3P|c4Preliminary|ta|rtast-ys01|rnFungal Suscep&tibility - AST-YS01|rr1|t2SU|t3Susceptibility|t4F|t5Final|t11|o1canpar|o2Candida& parapsilosis|ra|a1ab|a2Amphotericin B|a3<=0.25|a4S|ra|a1fct|a2Flucytosine|a3<=1&|a4S|ra|a1flu|a2Fluconazole|a3<=1|a4S|ra|a1vrc|a2Voriconazole|a3<=0.12|a4S|zz|f6
10:01:32 [Tx]
10:01:32 [Tx]
11:34:17 [Rx]mtrsl|i
dBMX|pi10884389|

pnInterf
ace|psa|
pda|p6Ad
ult|si|s

01|s111/08/2011|
s216:15|
s311/08/2011|s4
16:15|ci20111107
L410067|c01|ctbc
ilnk|cnBCI Downl
oad Exam|c3P|c4P
relimin
ary|ta|r
tast-p57
6|rnGram
 Positive Suscep
tibility
 - AST-P
576|rr2|
t2SU|t3S
uscepti

bility|t
4F|t5Fin
al|t11|o
1strpne|

o2Strept
ococcus 
pneumoni

ae|ra|a1
c|a2Chlo
ramphen

icol|a34
|a4S|ra|
a1e|a2Er

ythromyc
in|a3>=1
|a4R|ra|

a1imi|a2
Imipenem
|a30.5|a

4I|ra|a
1ofx|a2O
floxacin

|a32|a4S
|ra|a1pe
ng|a2Pen

icillin-
G|a3>=2|
a4R|ra|a

1pri|a2P
ristina
mycin|a3

<=2|a4S|
ra|a1rif
|a2Rifam

pin|a3<=
0.25|a4S
|ra|a1te

t|a2Tetr
acycline
|a3>=16

|a4R|ra|
a1sxt|a2
Trimetho

prim/Sul
fa|a380|
a4R|ra|a

1va|a2Va
ncomycin
|a3<=1|a

4S|ra|a1
lev|a2L
evofloxa
cin|a3<=


0.5|a4S|

ra|a1spx

|a2Sparf

loxacin|


a3<=0.12
|a4S|ra|

a1amx|a2


Amoxici

llin|a3>


=8|a4R|r

a|a1qda|


a2Quinup

ristin/D


alfopris


tin|a30.

5|a4S|ra


|a1ctr03


|a2Ceft

riaxone 


(non-men


ingitis)

|a3>=4|a

4R|ra|a1

lnz|a2Li

nezolid|


a3<=2|a4

S|ra|a1m


xf|a2Mo

xifloxac

in|a3<=0

.25|a4S|

ra|a1tax


03|a2Cef

otaxime 

(non-men

ingitis)


|a3>=4|a

4R|ra|a


1tel|a2T

elithrom
ycin|a3<


=0.25|a4

S|zz|78


11:34:43 [Rx]mtrsl|i
dBMX|pi10884389|

pnInterf
ace|psa|
pda|p6Ad
ult|si|s

01|s111/08/2011|
s216:15|
s311/08/2011|s4
16:15|ci20111107
L410067|c01|ctbc
ilnk|cnBCI Downl
oad Exam|c3P|c4P
relimin
ary|ta|r
tast-p57
6|rnGram
 Positive Suscep
tibility
 - AST-P
576|rr2|
t2SU|t3S
uscepti

bility|t
4F|t5Fin
al|t11|o
1strpne|

o2Strept
ococcus 
pneumoni

ae|ra|a1
c|a2Chlo
ramphen

icol|a34
|a4S|ra|
a1e|a2Er

ythromyc
in|a3>=1
|a4R|ra|

a1imi|a2
Imipenem
|a30.5|a

4I|ra|a
1ofx|a2O
floxacin

|a32|a4S
|ra|a1pe
ng|a2Pen

icillin-
G|a3>=2|
a4R|ra|a

1pri|a2P
ristina
mycin|a3

<=2|a4S|
ra|a1rif
|a2Rifam

pin|a3<=
0.25|a4S
|ra|a1te

t|a2Tetr
acycline
|a3>=16

|a4R|ra|
a1sxt|a2
Trimetho

prim/Sul
fa|a380|
a4R|ra|a

1va|a2Va
ncomycin
|a3<=1|a

4S|ra|a1
lev|a2L
evofloxa
cin|a3<=


0.5|a4S|

ra|a1spx

|a2Sparf

loxacin|


a3<=0.12
|a4S|ra|

a1amx|a2


Amoxici

llin|a3>


=8|a4R|r

a|a1qda|


a2Quinup

ristin/D


alfopris


tin|a30.

5|a4S|ra


|a1ctr03


|a2Ceft

riaxone 


(non-men


ingitis)

|a3>=4|a

4R|ra|a1

lnz|a2Li

nezolid|


a3<=2|a4

S|ra|a1m


xf|a2Mo

xifloxac

in|a3<=0

.25|a4S|

ra|a1tax


03|a2Cef

otaxime 

(non-men

ingitis)


|a3>=4|a

4R|ra|a


1tel|a2T

elithrom
ycin|a3<


=0.25|a4

S|zz|78


11:34:43 [Tx]
11:35:37 [Rx]&mtrsl|i
dBMX|pi10884389|

pnInterf
ace|psa|
pda|p6Ad
ult|si|s

01|s111/08/2011|
s216:15|
s311/08/2011|s4
16:15|ci20111107
L410067|c01|ctbc
ilnk|cnBCI Downl
oad Exam|c3P|c4P
relimin
ary|ta|r
tast-p57
6|rnGram
 Positive Suscep
tibility
 - AST-P
576|rr2|
t2SU|t3S
uscepti

bility|t
4F|t5Fin
al|t11|o
1strpne|

o2Strept
ococcus 
pneumoni

ae|ra|a1
c|a2Chlo
ramphen

icol|a34
|a4S|ra|
a1e|a2Er

ythromyc
in|a3>=1
|a4R|ra|

a1imi|a2
Imipenem
|a30.5|a

4I|ra|a
1ofx|a2O
floxacin

|a32|a4S
|ra|a1pe
ng|a2Pen

icillin-
G|a3>=2|
a4R|ra|a

1pri|a2P
ristina
mycin|a3

<=2|a4S|
ra|a1rif
|a2Rifam

pin|a3<=
0.25|a4S
|ra|a1te

t|a2Tetr
acycline
|a3>=16

|a4R|ra|
a1sxt|a2
Trimetho

prim/Sul
fa|a380|
a4R|ra|a

1va|a2Va
ncomycin
|a3<=1|a

4S|ra|a1
lev|a2L
evofloxa
cin|a3<=


0.5|a4S|

ra|a1spx

|a2Sparf

loxacin|


a3<=0.12
|a4S|ra|

a1amx|a2


Amoxici

llin|a3>


=8|a4R|r

a|a1qda|


a2Quinup

ristin/D


alfopris


tin|a30.

5|a4S|ra


|a1ctr03


|a2Ceft

riaxone 


(non-men


ingitis)

|a3>=4|a

4R|ra|a1

lnz|a2Li

nezolid|


a3<=2|a4

S|ra|a1m


xf|a2Mo

xifloxac

in|a3<=0

.25|a4S|

ra|a1tax


03|a2Cef

otaxime 

(non-men

ingitis)


|a3>=4|a

4R|ra|a


1tel|a2T

elithrom
ycin|a3<


=0.25|a4

S|zz|78


11:35:37 [Tx]
11:35:37 [Tx]
11:36:08 [Rx]&mtrsl|i
dBMX|pi10884389|

pnInterf
ace|psa|
pda|p6Ad
ult|si|s

01|s111/08/2011|
s216:15|
s311/08/2011|s4
16:15|ci20111107
L410067|c01|ctbc
ilnk|cnBCI Downl
oad Exam|c3P|c4P
relimin
ary|ta|r
tast-p57
6|rnGram
 Positive Suscep
tibility
 - AST-P
576|rr2|
t2SU|t3S
uscepti

bility|t
4F|t5Fin
al|t11|o
1strpne|

o2Strept
ococcus 
pneumoni

ae|ra|a1
c|a2Chlo
ramphen

icol|a34
|a4S|ra|
a1e|a2Er

ythromyc
in|a3>=1
|a4R|ra|

a1imi|a2
Imipenem
|a30.5|a

4I|ra|a
1ofx|a2O
floxacin

|a32|a4S
|ra|a1pe
ng|a2Pen

icillin-
G|a3>=2|
a4R|ra|a

1pri|a2P
ristina
mycin|a3

<=2|a4S|
ra|a1rif
|a2Rifam

pin|a3<=
0.25|a4S
|ra|a1te

t|a2Tetr
acycline
|a3>=16

|a4R|ra|
a1sxt|a2
Trimetho

prim/Sul
fa|a380|
a4R|ra|a

1va|a2Va
ncomycin
|a3<=1|a

4S|ra|a1
lev|a2L
evofloxa
cin|a3<=


0.5|a4S|

ra|a1spx

|a2Sparf

loxacin|


a3<=0.12
|a4S|ra|

a1amx|a2


Amoxici

llin|a3>


=8|a4R|r

a|a1qda|


a2Quinup

ristin/D


alfopris


tin|a30.

5|a4S|ra


|a1ctr03


|a2Ceft

riaxone 


(non-men


ingitis)

|a3>=4|a

4R|ra|a1

lnz|a2Li

nezolid|


a3<=2|a4

S|ra|a1m


xf|a2Mo

xifloxac

in|a3<=0

.25|a4S|

ra|a1tax


03|a2Cef

otaxime 

(non-men

ingitis)


|a3>=4|a

4R|ra|a


1tel|a2T

elithrom
ycin|a3<


=0.25|a4

S|zz|78


11:36:08 [Tx]
11:36:08 [Tx]
11:40:03 [Rx]
11:40:26 [Rx]&mtrsl|idBMX|pi10884389|pnInterface|psa|pda|p6Adult|si|s01|s111/08/2011|s216:15|s311/08/2011|s416:15|ci20111107L410067|c01|ctbcilnk|cnBCI Download Exam|c3P|c4Preliminary|ta|rtast-p576|rnGram Positive Susceptibility - AST-P576|rr2|t2SU|t3Susceptibility|t4F|t5Final|t11|o1strpne|o2Streptococcus pneumoniae|ra|a1c|a2Chloramphenicol|a34|a4S|ra|a1e|a2Erythromycin|a3>=1|a4R|ra|a1imi|a2Imipenem|a30.5|a4I|ra|a1ofx|a2Ofloxacin|a32|a4S|ra|a1peng|a2Penicillin-G|a3>=2|a4R|ra|a1pri|a2Pristinamycin|a3<=2|a4S|ra|a1rif|a2Rifampin|a3<=0.25|a4S|ra|a1tet|a2Tetracycline|a3>=16|a4R|ra|a1sxt|a2Trimethoprim/Sulfa|a380|a4R|ra|a1va|a2Vancomycin|a3<=1|a4S|ra|a1lev|a2Levofloxacin|a3<=0.5|a4S|ra|a1spx|a2Sparfloxacin|a3<=0.12|a4S|ra|a1amx|a2Amoxicillin|a3>=8|a4R|ra|a1qda|a2Quinupristin/Dalfopristin|a30.5|a4S|ra|a1ctr03|a2Ceftriaxone (non-meningitis)|a3>=4|a4R|ra|a1lnz|a2Linezolid|a3<=2|a4S|ra|a1mxf|a2Moxifloxacin|a3<=0.25|a4S|ra|a1tax03|a2Cefotaxime (non-meningitis)|a3>=4|a4R|ra|a1tel|a2Telithromycin|a3<=0.25|a4S|zz|78
11:40:26 [Tx]
11:40:26 [Tx]
11:41:32 [Rx]&mtrsl|idBMX|pi10884389|pnInterface|psa|pda|p6Adult|si|s01|s111/08/2011|s216:15|s311/08/2011|s416:15|ci20111107L410067|c01|ctbcilnk|cnBCI Download Exam|c3P|c4Preliminary|ta|rtast-p576|rnGram Positive Susceptibility - AST-P576|rr2|t2SU|t3Susceptibility|t4F|t5Final|t11|o1strpne|o2Streptococcus pneumoniae|ra|a1c|a2Chloramphenicol|a34|a4S|ra|a1e|a2Erythromycin|a3>=1|a4R|ra|a1imi|a2Imipenem|a30.5|a4I|ra|a1ofx|a2Ofloxacin|a32|a4S|ra|a1peng|a2Penicillin-G|a3>=2|a4R|ra|a1pri|a2Pristinamycin|a3<=2|a4S|ra|a1rif|a2Rifampin|a3<=0.25|a4S|ra|a1tet|a2Tetracycline|a3>=16|a4R|ra|a1sxt|a2Trimethoprim/Sulfa|a380|a4R|ra|a1va|a2Vancomycin|a3<=1|a4S|ra|a1lev|a2Levofloxacin|a3<=0.5|a4S|ra|a1spx|a2Sparfloxacin|a3<=0.12|a4S|ra|a1amx|a2Amoxicillin|a3>=8|a4R|ra|a1qda|a2Quinupristin/Dalfopristin|a30.5|a4S|ra|a1ctr03|a2Ceftriaxone (non-meningitis)|a3>=4|a4R|ra|a1lnz|a2Linezolid|a3<=2|a4S|ra|a1mxf|a2Moxifloxacin|a3<=0.25|a4S|ra|a1tax03|a2Cefotaxime (non-meningitis)|a3>=4|a4R|ra|a1tel|a2Telithromycin|a3<=0.25|a4S|zz|78
11:41:32 [Tx]
11:41:32 [Tx]
11:43:10 [Rx]&mtrsl|idBMX|pi10884389|pnInterface|psa|pda|p6Adult|si|s01|s111/08/2011|s216:15|s311/08/2011|s416:15|ci20111107L410067|c01|ctbcilnk|cnBCI Download Exam|c3P|c4Preliminary|ta|rtast-p576|rnGram Positive Susceptibility - AST-P576|rr2|t2SU|t3Susceptibility|t4F|t5Final|t11|o1strpne|o2Streptococcus pneumoniae|ra|a1c|a2Chloramphenicol|a34|a4S|ra|a1e|a2Erythromycin|a3>=1|a4R|ra|a1imi|a2Imipenem|a30.5|a4I|ra|a1ofx|a2Ofloxacin|a32|a4S|ra|a1peng|a2Penicillin-G|a3>=2|a4R|ra|a1pri|a2Pristinamycin|a3<=2|a4S|ra|a1rif|a2Rifampin|a3<=0.25|a4S|ra|a1tet|a2Tetracycline|a3>=16|a4R|ra|a1sxt|a2Trimethoprim/Sulfa|a380|a4R|ra|a1va|a2Vancomycin|a3<=1|a4S|ra|a1lev|a2Levofloxacin|a3<=0.5|a4S|ra|a1spx|a2Sparfloxacin|a3<=0.12|a4S|ra|a1amx|a2Amoxicillin|a3>=8|a4R|ra|a1qda|a2Quinupristin/Dalfopristin|a30.5|a4S|ra|a1ctr03|a2Ceftriaxone (non-meningitis)|a3>=4|a4R|ra|a1lnz|a2Linezolid|a3<=2|a4S|ra|a1mxf|a2Moxifloxacin|a3<=0.25|a4S|ra|a1tax03|a2Cefotaxime (non-meningitis)|a3>=4|a4R|ra|a1tel|a2Telithromycin|a3<=0.25|a4S|zz|78
11:43:10 [Tx]
11:43:10 [Tx]
11:43:43 [Rx]&mtrsl|idBMX|pi10884389|pnInterface|psa|pda|p6Adult|si|s01|s111/08/2011|s216:15|s311/08/2011|s416:15|ci20111107L410067|c01|ctbcilnk|cnBCI Download Exam|c3P|c4Preliminary|ta|rtast-p576|rnGram Positive Susceptibility - AST-P576|rr2|t2SU|t3Susceptibility|t4F|t5Final|t11|o1strpne|o2Streptococcus pneumoniae|ra|a1c|a2Chloramphenicol|a34|a4S|ra|a1e|a2Erythromycin|a3>=1|a4R|ra|a1imi|a2Imipenem|a30.5|a4I|ra|a1ofx|a2Ofloxacin|a32|a4S|ra|a1peng|a2Penicillin-G|a3>=2|a4R|ra|a1pri|a2Pristinamycin|a3<=2|a4S|ra|a1rif|a2Rifampin|a3<=0.25|a4S|ra|a1tet|a2Tetracycline|a3>=16|a4R|ra|a1sxt|a2Trimethoprim/Sulfa|a380|a4R|ra|a1va|a2Vancomycin|a3<=1|a4S|ra|a1lev|a2Levofloxacin|a3<=0.5|a4S|ra|a1spx|a2Sparfloxacin|a3<=0.12|a4S|ra|a1amx|a2Amoxicillin|a3>=8|a4R|ra|a1qda|a2Quinupristin/Dalfopristin|a30.5|a4S|ra|a1ctr03|a2Ceftriaxone (non-meningitis)|a3>=4|a4R|ra|a1lnz|a2Linezolid|a3<=2|a4S|ra|a1mxf|a2Moxifloxacin|a3<=0.25|a4S|ra|a1tax03|a2Cefotaxime (non-meningitis)|a3>=4|a4R|ra|a1tel|a2Telithromycin|a3<=0.25|a4S|zz|78
11:43:43 [Tx]
11:43:43 [Tx]
11:46:49 [Rx]&mtrsl|idBMX|pi10884389|pnInterface|psa|pda|p6Adult|si|s01|s111/08/2011|s216:15|s311/08/2011|s416:15|ci20111107L410067|c01|ctbcilnk|cnBCI Download Exam|c3P|c4Preliminary|ta|rtast-p576|rnGram Positive Susceptibility - AST-P576|rr2|t2SU|t3Susceptibility|t4F|t5Final|t11|o1strpne|o2Streptococcus pneumoniae|ra|a1c|a2Chloramphenicol|a34|a4S|ra|a1e|a2Erythromycin|a3>=1|a4R|ra|a1imi|a2Imipenem|a30.5|a4I|ra|a1ofx|a2Ofloxacin|a32|a4S|ra|a1peng|a2Penicillin-G|a3>=2|a4R|ra|a1pri|a2Pristinamycin|a3<=2|a4S|ra|a1rif|a2Rifampin|a3<=0.25|a4S|ra|a1tet|a2Tetracycline|a3>=16|a4R|ra|a1sxt|a2Trimethoprim/Sulfa|a380|a4R|ra|a1va|a2Vancomycin|a3<=1|a4S|ra|a1lev|a2Levofloxacin|a3<=0.5|a4S|ra|a1spx|a2Sparfloxacin|a3<=0.12|a4S|ra|a1amx|a2Amoxicillin|a3>=8|a4R|ra|a1qda|a2Quinupristin/Dalfopristin|a30.5|a4S|ra|a1ctr03|a2Ceftriaxone (non-meningitis)|a3>=4|a4R|ra|a1lnz|a2Linezolid|a3<=2|a4S|ra|a1mxf|a2Moxifloxacin|a3<=0.25|a4S|ra|a1tax03|a2Cefotaxime (non-meningitis)|a3>=4|a4R|ra|a1tel|a2Telithromycin|a3<=0.25|a4S|zz|78
11:46:49 [Tx]
11:46:49 [Tx]
11:57:29 [Rx]&mtrsl|idBMX|pi10884389|pnInterface|psa|pda|p6Adult|si|s01|s111/08/2011|s216:15|s311/08/2011|s416:15|ci20111107L410067|c01|ctbcilnk|cnBCI Download Exam|c3P|c4Preliminary|ta|rtast-p576|rnGram Positive Susceptibility - AST-P576|rr2|t2SU|t3Susceptibility|t4F|t5Final|t11|o1strpne|o2Streptococcus pneumoniae|ra|a1c|a2Chloramphenicol|a34|a4S|ra|a1e|a2Erythromycin|a3>=1|a4R|ra|a1imi|a2Imipenem|a30.5|a4I|ra|a1ofx|a2Ofloxacin|a32|a4S|ra|a1peng|a2Penicillin-G|a3>=2|a4R|ra|a1pri|a2Pristinamycin|a3<=2|a4S|ra|a1rif|a2Rifampin|a3<=0.25|a4S|ra|a1tet|a2Tetracycline|a3>=16|a4R|ra|a1sxt|a2Trimethoprim/Sulfa|a380|a4R|ra|a1va|a2Vancomycin|a3<=1|a4S|ra|a1lev|a2Levofloxacin|a3<=0.5|a4S|ra|a1spx|a2Sparfloxacin|a3<=0.12|a4S|ra|a1amx|a2Amoxicillin|a3>=8|a4R|ra|a1qda|a2Quinupristin/Dalfopristin|a30.5|a4S|ra|a1ctr03|a2Ceftriaxone (non-meningitis)|a3>=4|a4R|ra|a1lnz|a2Linezolid|a3<=2|a4S|ra|a1mxf|a2Moxifloxacin|a3<=0.25|a4S|ra|a1tax03|a2Cefotaxime (non-meningitis)|a3>=4|a4R|ra|a1tel|a2Telithromycin|a3<=0.25|a4S|zz|78
11:57:29 [Tx]
11:57:29 [Tx]
12:20:56 [Rx]&mtrsl|idBMX|pi10884389|pnInterface|psa|pda|p6Adult|si|s01|s111/08/2011|s216:15|s311/08/2011|s416:15|ci20111107L410067|c01|ctbcilnk|cnBCI Download Exam|c3P|c4Preliminary|ta|rtast-p576|rnGram Positive Susceptibility - AST-P576|rr2|t2SU|t3Susceptibility|t4F|t5Final|t11|o1strpne|o2Streptococcus pneumoniae|ra|a1c|a2Chloramphenicol|a34|a4S|ra|a1e|a2Erythromycin|a3>=1|a4R|ra|a1imi|a2Imipenem|a30.5|a4I|ra|a1ofx|a2Ofloxacin|a32|a4S|ra|a1peng|a2Penicillin-G|a3>=2|a4R|ra|a1pri|a2Pristinamycin|a3<=2|a4S|ra|a1rif|a2Rifampin|a3<=0.25|a4S|ra|a1tet|a2Tetracycline|a3>=16|a4R|ra|a1sxt|a2Trimethoprim/Sulfa|a380|a4R|ra|a1va|a2Vancomycin|a3<=1|a4S|ra|a1lev|a2Levofloxacin|a3<=0.5|a4S|ra|a1spx|a2Sparfloxacin|a3<=0.12|a4S|ra|a1amx|a2Amoxicillin|a3>=8|a4R|ra|a1qda|a2Quinupristin/Dalfopristin|a30.5|a4S|ra|a1ctr03|a2Ceftriaxone (non-meningitis)|a3>=4|a4R|ra|a1lnz|a2Linezolid|a3<=2|a4S|ra|a1mxf|a2Moxifloxacin|a3<=0.25|a4S|ra|a1tax03|a2Cefotaxime (non-meningitis)|a3>=4|a4R|ra|a1tel|a2Telithromycin|a3<=0.25|a4S|zz|78
12:20:56 [Tx]
12:20:56 [Tx]
